Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Medtronic Inc (MDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 121,535,104
  • Shares Outstanding, K 1,341,151
  • Annual Sales, $ 29,953 M
  • Annual Income, $ 3,104 M
  • 60-Month Beta 0.82
  • Price/Sales 4.05
  • Price/Cash Flow 13.37
  • Price/Book 2.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/19
See More
  • Average Estimate 1.47
  • Number of Estimates 13
  • High Estimate 1.49
  • Low Estimate 1.43
  • Prior Year 1.42
  • Growth Rate Est. (year over year) +3.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
89.50 +1.63%
on 03/08/19
94.20 -3.44%
on 03/15/19
-0.33 (-0.37%)
since 02/26/19
3-Month
81.66 +11.38%
on 01/08/19
94.59 -3.84%
on 02/19/19
+2.29 (+2.59%)
since 12/26/18
52-Week
76.62 +18.71%
on 04/02/18
100.15 -9.18%
on 09/26/18
+12.50 (+15.93%)
since 03/26/18

Most Recent Stories

More News
South Korea Spinal Implants and Vertebral Compression Fracture Market to 2024 Featuring Medtronic, DePuy Synthes, Stryker, Zimmer Biomet & Aesculap

The "Spinal Implants and Vertebral Compression Fracture Market - South Korea - 2018-2024" report has been added to ResearchAndMarkets.com's offering.

MDT : 91.07 (+0.50%)
Global ENT Surgery Navigation Software Industry Analysis 2019, Market Growth, Trends, Opportunities Forecast To 2024

SYK : 196.08 (+0.47%)
MDT : 91.07 (+0.50%)
Medtronic Launches Medtech Innovation Accelerator in Shanghai

Early-Stage Business Accelerator to Empower Local MedTech Innovation and Enhance Medtronic China's Industry Leadership

MHMNF : 54.5000 (unch)
MDT : 91.07 (+0.50%)
United States Barrett's Esophagus Ablation Devices Market Report 2019 - Forecasts to 2025 - ResearchAndMarkets.com

The "Barrett's Esophagus Ablation Devices Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.

MDT : 91.07 (+0.50%)
Global Blood Glucose Monitoring Devices Market Outlook and Forecast 2019-2024: Major Vendors are F. Hoffmann-La Roche, Abbott, Dexcom, LifeScan, Medtronic, & Ascensia Diabetes Care

The "Blood Glucose Monitoring Devices Market - Global Outlook and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

MDT : 91.07 (+0.50%)
After Yesterday's Decline of 1.36%, Medtronic Plc Offers Investors Better Value

Medtronic Plc (NYSE:MDT) traded in a range yesterday that spanned from a low of $90.85 to a high of $91.72. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $91.31...

MDT : 91.07 (+0.50%)
Watch for Medtronic Plc to Potentially Rebound After Falling 1.36% Yesterday

Medtronic Plc (NYSE:MDT) traded in a range yesterday that spanned from a low of $90.85 to a high of $91.72. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $91.31...

MDT : 91.07 (+0.50%)
Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results

The use of Abbott's (ABT) HeartMate 3 pump can efficiently prolong life -term and improve the quality of life for advanced heart failure patients.

ABT : 79.00 (+0.98%)
SYK : 196.08 (+0.47%)
BSX : 37.84 (+0.53%)
MDT : 91.07 (+0.50%)
Edwards Lifesciences Presents Positive Partner 3 Trial Data

Edwards Lifesciences (EW) expects SAPIEN 3 to gain FDA approval for the low-risk indication in late-2019.

EW : 190.28 (+0.46%)
ABT : 79.00 (+0.98%)
BSX : 37.84 (+0.53%)
MDT : 91.07 (+0.50%)
Why Is Medtronic (MDT) Down 1.2% Since Last Earnings Report?

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MDT : 91.07 (+0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade MDT with:

Business Summary

Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders...

See More

Key Turning Points

2nd Resistance Point 91.49
1st Resistance Point 91.05
Last Price 91.07
1st Support Level 90.10
2nd Support Level 89.58

See More

52-Week High 100.15
Fibonacci 61.8% 91.16
Last Price 91.07
Fibonacci 50% 88.39
Fibonacci 38.2% 85.61
52-Week Low 76.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar